Moreover, inhibiting CD14 expression in tumor cells reduced the levels of neutrophil-recruiting chemokines by suppressing NFκB signaling, leading to a significant decrease in neutrophil infiltration within the TME. Here, NFKB1 is linked to neoplasm.